Results 11 to 20 of about 11,774 (135)

A long-term survivor of recurrent esophagogastric junction adenocarcinoma treated with multidisciplinary therapy: a case report

Surgical Case Reports, 2020
Background Patients with esophagogastric junction cancer are increasing in Western and Eastern countries. Conversely, the clinical significance of surgical resection remains controversial in these patients.
Takako Tanaka, Takaaki Arigami, Yoshikazu Uenosono, Shigehiro Yanagita, Daisuke Matsushita, Keishi Okubo, Takashi Kijima, Yasuto Uchikado, Yoshiaki Kita, Shinichiro Mori, Ken Sasaki, Itaru Omoto, Hiroshi Kurahara, Kosei Maemura, Sumiya Ishigami, Shoji Natsugoe   +15 more
doaj   +1 more source

Insights into the endoscopic management of esophageal achalasia

Therapeutic Advances in Gastrointestinal Endoscopy, 2021
Achalasia is a primary esophageal motility disorder characterized by the loss of inhibitory neurons in the myenteric plexus, resulting in impaired relaxation of the esophagogastric junction. Achalasia is an incurable disease, and the treatment modalities
Elizabeth Brindise, Mouen A. Khashab, Rami El Abiad   +2 more
doaj   +1 more source

Surgical and oncological outcome after extended lymph node dissection for carcinoma of the stomach and the esophagogastric junction: a retrospective analysis from an experienced single center

Archives of Medical Science, 2021
Introduction Gastric cancer remains the fourth leading cause of cancer-related death in Europe, while the proportion of adenocarcinomas of the esophagogastric junction has risen by more than one third over recent years.
Dimitrios Raptis, Matthias Maak, Christian Krautz, Susanne Merkel, Maximilian Brunner, Abbas Agaimy, Arndt Hartmann, Sabine Semrau, Oliver Ott, Rainer Fietkau, Jürgen Siebler, Robert Grützmann, Werner Hohenberger, Claus-Wilhelm Schildberg   +13 more
doaj   +1 more source

Factors related to lymph node metastasis in Siewert type Ⅲ carcinoma of esophagogastric junction

Di-san junyi daxue xuebao, 2019
Objective To investigate the influencing factors for lymph node metastasis in Siewert type Ⅲ carcinoma of esophagogastric junction. Methods A total of 162 patients with Siewert type Ⅲ carcinoma of esophagogastric junction undergoing radical surgery in ...
SHEN Yonghua, ZHU Yunxiang, TANG Xiaofei, DING Zhiyan   +3 more
doaj   +1 more source

A case of primary malignant melanoma of the esophagogastric junction with abscopal effect after nivolumab administration

Surgical Case Reports, 2021
Background The abscopal effect is a rare phenomenon in which local irradiation causes tumor regression outside the irradiated area. There have been no reports of abscopal effect in patients with gastrointestinal melanoma with metastasis.
Takahisa Yamaguchi, Sachio Fushida, Jun Kinoshita, Hiroto Saito, Mari Shimada, Shiro Terai, Hideki Moriyama, Koichi Okamoto, Keishi Nakamura, Itasu Ninomiya, Noriyuki Inaki   +10 more
doaj   +1 more source

Evaluation of the incidence of splenic hilar lymph node metastasis in patients operated on for esophagogastric junction cancer

Nowotwory, 2023
INTRODUCTION: The purpose of this study is to evaluate the effect of esophagogastric junction cancer (EGJC) staging on the risk of splenic hilar lymph node involvement. MATERIAL AND METHODS: 312 patients with EGJC after R0 surgery were analyzed; 118 (38%)
Tomasz Olesiński, Marek Szpakowski, Wojciech Każmierczak, Urszula Sulkowska, Andrzej Rutkowski   +4 more
doaj   +1 more source

Study protocol of a randomized phase III trial of comparing preoperative chemoradiation with preoperative chemotherapy in patients with locally advanced gastric cancer or esophagogastric junction adenocarcinoma: PREACT

BMC Cancer, 2019
Background The prognosis of patients with locally advanced gastric cancer or esophagogastric junction adenocarcinoma is still dismal. There are no standard treatment strategies for these patients.
Xiaowen Liu, Jiejie Jin, Hong Cai, Hua Huang, Guangfa Zhao, Ye Zhou, Jianghong Wu, Chunyan Du, Ziwen Long, Yantian Fang, Mingze Ma, Guichao Li, Menglong Zhou, Jiliang Yin, Xiaodong Zhu, Ji zhu, Weiqi Sheng, Dan Huang, Hui Zhu, Zhaozhen Zhang, Qi Lu, Li Xie, Zhen Zhang, Yanong Wang   +23 more
doaj   +1 more source

Diagnostic performance in T staging for patients with esophagogastric junction cancer using high-resolution MRI: a comparison with conventional MRI at 3 tesla

Cancer Imaging, 2019
Background To investigate and compare the diagnostic performance in T staging for patients with esophagogastric junction cancer using high-resolution magnetic resonance imaging (HR MRI), as compared with conventional MRI at 3 Tesla.
Yuan Yuan, Luguang Chen, Shengnan Ren, Zhen Wang, Yukun Chen, Aiguo Jin, Shuai Li, Xu Fang, Tiegong Wang, Yun Bian, Qingsong Yang, Chenguang Bai, Qiang Hao, Jianping Lu   +13 more
doaj   +1 more source

Lack of EGFR mutations benefiting gefitinib treatment in adenocarcinoma of esophagogastric junction

World Journal of Surgical Oncology, 2012
Background The epidermal growth factor receptor (EGFR) inhibitor, gefitinib, has been reported to successfully treat advanced non-small cell lung cancer patients with genetic mutations in EGFR.
Wang Wen-Ping, Wang Kang-Ning, Gao Qiang, Chen Long-Qi   +3 more
doaj   +1 more source

The efficacy of the application of the curative criteria of the 5rd edition Japanese gastric cancer treatment guidelines for early adenocarcinoma of the esophagogastric junction treated by endoscopic submucosal dissection

The Saudi Journal of Gastroenterology, 2021
Background: The curative criteria after endoscopic submucosal dissection for early gastric carcinoma were updated by the Japanese Gastric Cancer Association.
Zhihao Chen, Yong Liu, Lizhou Dou, Yueming Zhang, Shun He, Guiqi Wang   +5 more
doaj   +1 more source